| Literature DB >> 29464808 |
Pietro Ameri1, Marco Canepa1, Markus S Anker2, Yury Belenkov3, Jutta Bergler-Klein4, Alain Cohen-Solal5, Dimitrios Farmakis6, Teresa López-Fernández7, Mitja Lainscak8, Radek Pudil9, Frank Ruschitska10, Petar Seferovic11, Gerasimos Filippatos6, Andrew Coats12, Thomas Suter13, Stephan Von Haehling14, Fortunato Ciardiello15, Rudolf A de Boer16, Alexander R Lyon17, Carlo G Tocchetti18.
Abstract
Cancer and heart failure (HF) are common medical conditions with a steadily rising prevalence in industrialized countries, particularly in the elderly, and they both potentially carry a poor prognosis. A new diagnosis of malignancy in subjects with pre-existing HF is not infrequent, and challenges HF specialists as well as oncologists with complex questions relating to both HF and cancer management. An increased incidence of cancer in patients with established HF has also been suggested. This review paper summarizes the epidemiology and the prognostic implications of cancer occurrence in HF, the impact of pre-existing HF on cancer treatment decisions and the impact of cancer on HF therapeutic options, while providing some practical suggestions regarding patient care and highlighting gaps in knowledge.Entities:
Keywords: Cancer; Co-morbidity; Heart failure; Prognosis; Therapy
Mesh:
Year: 2018 PMID: 29464808 DOI: 10.1002/ejhf.1165
Source DB: PubMed Journal: Eur J Heart Fail ISSN: 1388-9842 Impact factor: 15.534